Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders

Molecular BioSystems

Volumn 8, Issue 10, 2012, Pages 2503-2512

  Andreazza, Ana Cristina ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOSINE; DNA; GUANOSINE; PROTEIN;

ADULT; DNA METHYLATION; EPIGENETICS; GENETICS; HUMAN; MENTAL DISEASE; METABOLISM; MOLECULARLY TARGETED THERAPY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEOMICS; REVIEW;

ADULT; BIOLOGICAL MARKERS; CYTOSINE; DNA; DNA METHYLATION; EPIGENOMICS; GUANOSINE; HUMANS; MENTAL DISORDERS; MOLECULAR TARGETED THERAPY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; PROTEOMICS;

EID: 84865765591     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c2mb25118c     Document Type: Review

References (117)

1. R. C. Kessler O. Demler R. G. Frank M. Olfson H. A. Pincus E. E. Walters P. Wang K. B. Wells A. M. Zaslavsky Prevalence and treatment of mental disorders, 1990 to 2003 N. Engl. J. Med. 2005 352 24 2515 2523
2. K. R. Merikangas R. Jin J. P. He R. C. Kessler S. Lee N. A. Sampson M. C. Viana L. H. Andrade C. Hu E. G. Karam M. Ladea M. E. Medina-Mora Y. Ono J. Posada-Villa R. Sagar J. E. Wells Z. Zarkov Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Arch. Gen. Psychiatry 2011 68 3 241 251
3. A. C. Altamura M. Serati A. Albano R. A. Paoli I. D. Glick B. Dell'Osso An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses Eur. Arch. Psychiatry Clin. Neurosci. 2011 261 7 489 508
4. F. K. Gazalle A. C. Andreazza K. M. Cereser P. C. Hallal A. Santin F. Kapczinski Clinical impact of late diagnose of bipolar disorder J. Affective Disord. 2005 86 2-3 313 316
5. F. K. Gazalle P. C. Hallal A. C. Andreazza B. N. Frey M. Kauer-Sant'Anna F. Weyne S. C. da Costa A. Santin F. Kapczinski Manic symptoms and quality of life in bipolar disorder Psychiatry Res. 2007 153 1 33 38
6. T. R. Insel B. J. Sahakian Drug research: a plan for mental illness Nature 2012 483 7389 269
7. D. Martins-de-Souza P. C. Guest F. L. Guest C. Bauder H. Rahmoune S. Pietsch S. Roeber H. Kretzschmar D. Mann A. Baborie S. Bahn Characterization of the human primary visual cortex and cerebellum proteomes using shotgun mass spectrometry-data-independent analyses Proteomics 2011 12 3 500 504
8. M. Berk S. Dodd M. Kauer-Sant'anna G. S. Malhi M. Bourin F. Kapczinski T. Norman Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder Acta Psychiatr. Scand., Suppl. 2007 434 41 49
9. J. S. Rao M. Kellom E. A. Reese S. I. Rapoport H. W. Kim Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients J. Affective Disord. 2012 136 1-2 63 71
10. L. N. Yatham P. F. Liddle R. W. Lam M. J. Adam K. Solomons M. Chinnapalli T. J. Ruth A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania Bipolar Disord. 2005 7 suppl 5 53 57
11. N. Buttner S. Bhattacharyya J. Walsh F. M. Benes DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia Schizophr. Res. 2007 93 1-3 33 41
12. G. Rajkowska A. Halaris L. D. Selemon Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder Biol. Psychiatry 2001 49 9 741 752
13. B. I. Goldstein A. Fagiolini P. Houck D. J. Kupfer Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States Bipolar Disord. 2009 11 6 657 662
14. C. Konradi S. E. Sillivan H. B. Clay Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis Neurobiol. Dis. 2012 45 1 37 47
15. T. Kato Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder Cell Calcium 2008 44 1 92 102
16. M. J. Kempton G. Ruberto E. Vassos R. Tatarelli P. Girardi D. Collier S. Frangou Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals Am. J. Psychiatry 2009 166 12 1413 1414
17. H. B. Clay S. Sillivan C. Konradi Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia Int. J. Dev. Neurosci. 2010 29 3 311 324
18. A. D. Gigante L. T. Young L. N. Yatham A. C. Andreazza F. G. Nery L. T. Grinberg H. Heinsen B. Lafer Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis Int. J. Neuropsychopharmacol. 2010 14 8 1075 1089
19. T. Kato O. C. Stine F. J. McMahon R. R. Crowe Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder Biol. Psychiatry 1997 42 10 871 875
20. A. C. Andreazza B. N. Frey B. Erdtmann M. Salvador F. Rombaldi A. Santin C. A. Goncalves F. Kapczinski DNA damage in bipolar disorder Psychiatry Res. 2007 153 1 27 32
21. J. F. Wang L. Shao X. Sun L. T. Young Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia Bipolar Disord. 2009 11 5 523 529
22. F. M. Benes D. Matzilevich R. E. Burke J. Walsh The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia Mol. Psychiatry 2006 11 3 241 251
23. T. Kato J. Murashita A. Kamiya T. Shioiri N. Kato T. Inubushi Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity Eur. Arch. Psychiatry Clin. Neurosci. 1998 248 6 301 306
24. A. C. Andreazza L. Shao J. F. Wang L. T. Young Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder Arch. Gen. Psychiatry 2010 67 4 360 368
25. J. W. Gawryluk J. F. Wang A. C. Andreazza L. Shao L. T. Young Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders Int. J. Neuropsychopharmacol. 2011 14 1 123 130
26. S. L. Dubovsky M. Thomas A. Hijazi J. Murphy Intracellular calcium signalling i peripheral cells of patients with bipolar affective disorder Eur. Arch. Psychiatry Clin. Neurosci. 1994 243 5 229 234
27. T. Perova M. J. Wasserman P. P. Li J. J. Warsh Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder Int. J. Neuropsychopharmacol. 2008 11 2 185 196
28. M. F. Beal Oxidatively modified proteins in aging and disease Free Radicals Biol. Med. 2002 32 9 797 803
29. I. Dalle-Donne R. Rossi D. Giustarini R. Colombo A. Milzani Actin S-glutathionylation: evidence against a thiol-disulphide exchange mechanism Free Radicals Biol. Med. 2003 35 10 1185 1193
30. Y. Wang J. Yang J. Yi Redox sensing by proteins: oxidative modifications on cysteines and the consequent events Antioxid. Redox Signaling 2012 16 7 649 657
31. A. Martinez M. Portero-Otin R. Pamplona I. Ferrer Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates Brain Pathol. 2010 20 2 281 297
32. M. R. Branco G. Ficz W. Reik Uncovering the role of 5- hydroxymethylcytosine in the epigenome Nat. Rev. Genet. 2012 13 1 7 13
33. J. L. García-Giménez A. M. Ledesma I. Esmoris C. Romá-Mateo P. Sanz J. Viña F. V. Pallardó Histone carbonylation occurs in proliferating cells Free Radical Biol. Med. 2012 52 8 1453 1464
34. C. Chinopoulos V. Adam-Vizi Mitochondrial Ca2+ sequestration and precipitation revisited FEBS J. 2010 277 18 3637 3651
35. U. Brandt S. Kerscher S. Drose K. Zwicker V. Zickermann Proton pumping by NADH:ubiquinone oxidoreductase. A redox driven conformational change mechanism? FEBS Lett. 2003 545 1 9 17
36. A. K. Reeve K. J. Krishnan D. M. Turnbull Age related mitochondrial degenerative disorders in humans Biotechnol. J. 2008 3 6 750 756
37. D. R. Green G. Kroemer The pathophysiology of mitochondrial cell death Science 2004 305 5684 626 629
38. M. P. Murphy How mitochondria produce reactive oxygen species Biochem. J. 2009 417 1 1 13
39. M. Naoi W. Maruyama M. Shamoto-Nagai H. Yi Y. Akao M. Tanaka Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders Mol. Neurobiol. 2005 31 1-3 81 93
40. B. Halliwell Biochemistry of oxidative stress Biochem. Soc. Trans. 2007 35 Pt 5 1147 1150
41. H. Sies Oxidative stress: from basic research to clinical application Am. J. Med. 1991 91 3C 31S 38S
42. H. Miki Y. Funato Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species J. Biochem. (Tokyo) 2012 151 3 255 261
43. M. Mancuso G. Siciliano M. Filosto L. Murri Mitochondrial dysfunction and Alzheimer's disease: new developments J. Alzheimer's Dis. 2006 9 2 111 117
44. L. H. Wong Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells Epigenomics 2010 2 5 639 655
45. T. P. Szatrowski C. F. Nathan Production of large amounts of hydrogen peroxide by human tumor cells Cancer Res. 1991 51 3 794 798
46. Y. A. Suh R. S. Arnold B. Lassegue J. Shi X. Xu D. Sorescu A. B. Chung K. K. Griendling J. D. Lambeth Cell transformation by the superoxide-generating oxidase Mox1 Nature 1999 401 6748 79 82
47. I. K. Sundar S. Caito H. Yao I. Rahman Oxidative stress, thiol redox signaling methods in epigenetics Methods Enzymol. 2010 474 213 244
48. B. J. Song S. K. Suh K. H. Moon A simple method to systematically study oxidatively modified proteins in biological samples and its applications Methods Enzymol. 2010 473 251 264
49. D. A. Butterfield R. Sultana Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics Methods Enzymol. 2008 440 295 308
50. D. A. Butterfield R. Sultana Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders Expert Rev. Proteomics 2008 5 2 157 160
51. R. Sultana M. Perluigi S. F. Newman W. M. Pierce C. Cini R. Coccia D. A. Butterfield Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease Antioxid. Redox Signaling 2010 12 3 327 336
52. B. Halliwell M. Whiteman Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 2004 142 2 231 255
53. S. Padilla-Parra M. Tramier FRET microscopy in the living cell: Different approaches, strengths and weaknesses Bioessays 2012 34 5 369 376
54. J. Bacart C. Corbel R. Jockers S. Bach C. Couturier The BRET technology and its application to screening assays Biotechnol. J. 2008 3 3 311 324
55. F. Festy S. M. Ameer-Beg T. Ng K. Suhling Imaging proteins in vivo using fluorescence lifetime microscopy Mol. Biosyst. 2007 3 6 381 391
56. J. Petschnigg V. Wong J. Snider I. Stagljar Investigation of membrane protein interactions using the split-ubiquitin membrane yeast two-hybrid system Methods Mol. Biol. (Totowa, N. J.) 2012 812 225 244
57. J. Kim J. Lee D. Kwon H. Lee R. Grailhe A comparative analysis of resonance energy transfer methods for Alzheimer related protein-protein interactions in living cells Mol. Biosyst. 2011 7 11 2991 2996
58. S. Ferré G. Navarro V. Casadó A. Cortés J. Mallol E. I. Canela C. Lluís R. Franco G protein-coupled receptor heteromers as new targets for drug development Prog. Mol. Biol. Transl. Sci. 2010 91 41 52
59. F. Matarese E. Carrillo-de Santa Pau H. G. Stunnenberg 5-Hydroxymethylcytosine: a new kid on the epigenetic block? Mol. Syst. Biol. 2011 7 562
60. K. Lertratanangkoon C. J. Wu N. Savaraj M. L. Thomas Alterations of DNA methylation by glutathione depletion Cancer Lett. (Shannon, Irel.) 1997 120 2 149 156
61. M. J. Hitchler F. E. Domann An epigenetic perspective on the free radical theory of development Free Radicals Biol. Med. 2007 43 7 1023 1036
62. T. C. Wang Y. S. Song H. Wang J. Zhang S. F. Yu Y. E. Gu T. Chen Y. Wang H. Q. Shen G. Jia Oxidative DNA damage and global DNA hypomethylation are related to folate deficiency in chromate manufacturing workers J. Hazard. Mater. 2012 213-214 440 446
63. N. Chia L. Wang X. Lu M. C. Senut C. Brenner D. M. Ruden Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress Epigenetics 2011 6 7 853 856
64. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Clarendon Press, Oxford, 4 edn, 2007
65. D. Marazziti S. Baroni M. Picchetti P. Landi S. Silvestri E. Vatteroni M. Catena Dell'Osso Psychiatric disorders and mitochondrial dysfunctions Eur. Rev. Med. Pharmacol. Sci. 2012 16 2 270 275
66. K. Iwamoto C. Kakiuchi M. Bundo K. Ikeda T. Kato Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders Mol. Psychiatry 2004 9 4 406 416
67. C. Konradi M. Eaton M. L. MacDonald J. Walsh F. M. Benes S. Heckers Molecular evidence for mitochondrial dysfunction in bipolar disorder Arch. Gen. Psychiatry 2004 61 3 300 308
68. X. Sun J. F. Wang M. Tseng L. T. Young Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder J. Psychiatry Neurosci. 2006 31 3 189 196
69. A. Boveris B. Chance The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen Biochem. J. 1973 134 3 707 716
70. J. F. Turrens A. Boveris Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria Biochem. J. 1980 191 2 421 427
71. C. Xu P. P. Li J. L. Kennedy M. Green B. Hughes R. G. Cooke S. V. Parikh J. J. Warsh Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder Bipolar Disord. 2008 10 1 105 110
72. S. Washizuka K. Iwamoto C. Kakiuchi M. Bundo T. Kato Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia J. Neurosci. Res. 2009 63 3 199 204
73. M. Kuloglu B. Ustundag M. Atmaca H. Canatan A. E. Tezcan N. Cinkilinc Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder Cell Biochem. Funct. 2002 20 2 171 175
74. H. A. Savas H. S. Gergerlioglu F. Armutcu H. Herken H. R. Yilmaz E. Kocoglu S. Selek H. Tutkun S. S. Zoroglu O. Akyol Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes World J. Biol. Psychiatry 2006 7 1 51 55
75. J. W. Gawryluk J. F. Wang A. C. Andreazza L. Shao L. N. Yatham L. T. Young Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia Int. J. Neuropsychopharmacol. 2011 14 8 1069 1074
76. R. Machado-Vieira A. C. Andreazza C. I. Viale V. Zanatto V. Cereser, Jr. R. da Silva Vargas F. Kapczinski L. V. Portela D. O. Souza M. Salvador V. Gentil Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects Neurosci. Lett. 2007 421 1 33 36
77. H. A. Savas H. Herken M. Yurekli E. Uz H. Tutkun S. S. Zoroglu M. E. Ozen B. Cengiz O. Akyol Possible role of nitric oxide and adrenomedullin in bipolar affective disorder Neuropsychobiology 2002 45 2 57 61
78. S. Selek H. A. Savas H. S. Gergerlioglu F. Bulbul E. Uz M. Yumru The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode J. Affective Disord. 2008 107 1-3 89 94
79. B. K. Bitanihirwe T. U. Woo Oxidative stress in schizophrenia: an integrated approach Neurosci. Biobehav. Rev. 2010 35 3 878 893
80. A. Ciobica M. Padurariu I. Dobrin C. Stefanescu R. Dobrin Oxidative stress in schizophrenia - focusing on the main markers Psychiatr. Danubina 2011 23 3 237 245
81. N. Uranova D. Orlovskaya O. Vikhreva I. Zimina N. Kolomeets V. Vostrikov V. Rachmanova Electron microscopy of oligodendroglia in severe mental illness Brain Res. Bull. 2001 55 5 597 610
82. S. Prabakaran J. E. Swatton M. M. Ryan S. J. Huffaker J. T. Huang J. L. Griffin M. Wayland T. Freeman F. Dudbridge K. S. Lilley N. A. Karp S. Hester D. Tkachev M. L. Mimmack R. H. Yolken M. J. Webster E. F. Torrey S. Bahn Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress Mol. Psychiatry 2004 9 7 684 697
83. I. Maurer S. Zierz H. Moller Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia Schizophr. Res. 2001 48 1 125 136
84. R. Karry E. Klein D. Ben Shachar Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study Biol. Psychiatry 2004 55 7 676 684
85. J. A. Prince K. Blennow C. G. Gottfries I. Karlsson L. Oreland Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics Neuropsychopharmacology 1999 21 3 372 379
86. K. Q. Do A. H. Trabesinger M. Kirsten-Kruger C. J. Lauer U. Dydak D. Hell F. Holsboer P. Boesiger M. Cuenod Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo Eur. J. Neurosci. 2000 12 10 3721 3728
87. J. K. Yao S. Leonard R. Reddy Altered glutathione redox state in schizophrenia Dis. Markers 2006 22 1-2 83 93
88. M. Tosic J. Ott S. Barral P. Bovet P. Deppen F. Gheorghita M. L. Matthey J. Parnas M. Preisig M. Saraga A. Solida S. Timm A. G. Wang T. Werge M. Cuenod K. Q. Do Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene Am. J. Hum. Genet. 2006 79 3 586 592
89. M. Kunz C. S. Gama A. C. Andreazza M. Salvador K. M. Cereser F. A. Gomes P. S. Belmonte-de-Abreu M. Berk F. Kapczinski Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia Prog. Neuropsychopharmacol. Biol. Psychiatry 2008 32 7 1677 1681
90. M. Padurariu A. Ciobica I. Dobrin C. Stefanescu Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics Neurosci. Lett. 479 3 317 320
91. V. Medina-Hernandez J. Ramos-Loyo S. Luquin L. F. Sanchez J. Garcia-Estrada A. Navarro-Ruiz Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics J. Psychiatry Res. 2007 41 8 652 658
92. Y. Che J. F. Wang L. Shao T. Young Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness J. Psychiatry Neurosci. 2010 35 5 296 302
93. T. Lu Y. Pan S. Y. Kao C. Li I. Kohane J. Chan B. A. Yankner Gene regulation and DNA damage in the ageing human brain Nature 2004 429 6994 883 891
94. G. Saretzki T. Von Zglinicki Replicative aging, telomeres, and oxidative stress Ann. N. Y. Acad. Sci. 2002 959 24 29
95. N. M. Simon J. W. Smoller K. L. McNamara R. S. Maser A. K. Zalta M. H. Pollack A. A. Nierenberg M. Fava K. K. Wong Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging Biol. Psychiatry 2006 60 5 432 435
96. O. M. Wolkowitz S. H. Mellon E. S. Epel J. Lin V. I. Reus R. Rosser H. Burke M. Compagnone J. C. Nelson F. S. Dhabhar E. H. Blackburn Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response Mol. Psychiatry 2012 17 2 164 172
97. T. Lu Y. Pan S. Y. Kao C. Li I. Kohane J. Chan B. A. Yankner Gene regulation and DNA damage in the ageing human brain Nature 2004 429 6994 883 891
98. M. Hayashi R. Miyata N. Tanuma Oxidative stress in developmental brain disorders Adv. Exp. Med. Biol. 2012 724 278 290
99. M. Focking P. Dicker J. A. English K. O. Schubert M. J. Dunn D. R. Cotter Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3 Arch. Gen. Psychiatry 2011 68 5 477 488
100. D. Martins-de-Souza P. C. Guest N. Vanattou-Saifoudine L. W. Harris S. Bahn Proteomic technologies for biomarker studies in psychiatry: advances and needs Int. Rev. Neurobiol. 2011 101 65 94
101. M. R. Baig E. Navaira M. A. Escamilla H. Raventos C. Walss-Bass Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: a possible mechanism for antipsychotic-induced metabolic alterations J. Psychiatry Pract. 2010 16 5 325 333
102. H. M. Abdolmaleky S. Yaqubi P. Papageorgis A. W. Lambert S. Ozturk V. Sivaraman S. Thiagalingam Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder Schizophr. Res. 2011 129 2-3 183 190
103. H. M. Abdolmaleky C. L. Smith J. R. Zhou S. Thiagalingam Epigenetic alterations of the dopaminergic system in major psychiatric disorders Methods Mol. Biol. (Totowa, N. J.) 2008 448 187 212
104. H. M. Abdolmaleky K. H. Cheng S. V. Faraone M. Wilcox S. J. Glatt F. Gao C. L. Smith R. Shafa B. Aeali J. Carnevale H. Pan P. Papageorgis J. F. Ponte V. Sivaraman M. T. Tsuang S. Thiagalingam Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder Hum. Mol. Genet. 2006 15 21 3132 3145
105. G. Kuratomi K. Iwamoto M. Bundo I. Kusumi N. Kato N. Iwata N. Ozaki T. Kato Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins Mol. Psychiatry 2008 13 4 429 441
106. M. P. Boks N. M. de Jong M. J. Kas C. H. Vinkers C. Fernandes R. S. Kahn J. Mill R. A. Ophoff Current status and future prospects for epigenetic psychopharmacology Epigenetics 2012 7 1 20 28
107. I. Singh N. Rose Biomarkers in psychiatry Nature 2009 460 7252 202 207
108. A. C. Andreazza M. Kauer-Sant'anna B. N. Frey D. J. Bond F. Kapczinski L. T. Young L. N. Yatham Oxidative stress markers in bipolar disorder: a meta-analysis J. Affective Disord. 2008 111 2-3 135 144
109. K. G. Victor J. M. Rady J. V. Cross D. J. Templeton Proteomic Profile of Reversible Protein Oxidation Using PROP, Purification of Reversibly Oxidized Proteins PLoS One 2012 7 2 e32527
110. J. M. Looney H. M. Childs The Lactic Acid And Glutathione Content of The Blood of Schizophrenic Patients J. Clin. Invest. 1934 13 6 963 968
111. C. Carmeli M. G. Knyazeva M. Cuenod K. Q. Do Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial PLoS One 2012 7 2 e29341
112. D. A. Butterfield A. Gnjec H. F. Poon A. Castegna W. M. Pierce J. B. Klein R. N. Martins Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment J. Alzheimer's Dis. 2006 10 4 391 397
113. D. Martins-de-Souza P. C. Guest F. L. Guest C. Bauder H. Rahmoune S. Pietsch S. Roeber H. Kretzschmar D. Mann A. Baborie S. Bahn Characterization of the human primary visual cortex and cerebellum proteomes using shotgun mass spectrometry-data-independent analyses Proteomics 2012 12 3 500 504
114. M. E. Lee K. Singh J. Snider A. Shenoy C. M. Paumi I. Stagljar H. O. Park The Rho1 GTPase acts together with a vacuolar glutathione S-conjugate transporter to protect yeast cells from oxidative stress Genetics 2011 188 4 859 870
115. Y. L. Deribe P. Wild A. Chandrashaker J. Curak M. H. Schmidt Y. Kalaidzidis N. Milutinovic I. Kratchmarova L. Buerkle M. J. Fetchko P. Schmidt S. Kittanakom K. R. Brown I. Jurisica B. Blagoev M. Zerial I. Stagljar I. Dikic Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6 Sci. Signaling 2009 2 102 ra84
116. C. Y. Lin A. Sawa H. Jaaro-Peled Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models Neurobiol. Dis. 2012 45 1 48 56
117. A. Martinez E. Dalfo G. Muntane I. Ferrer Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy J. Neural Transm. 2008 115 1 59 66